As shown in the direct killing assays (Figures 7A and 7B) CRAFT CAR T-cells, like unedited CAR T-cells, exhibited cytotoxicity against BAFF-R KO Nalm-6 cells only in the presence of blinatumomab, which captured target tumor cells via the CD19 antigen. Here, CD19 is linked to neoplasm.